通讯员王万钰扬子晚报/紫牛新闻记者张建波 《中华人民共和国刑法》第一百七十七条规定：伪造、变造金融票证的，处五年以下有期徒刑或者拘 役，并处或者单处二万元以上二十万元以下罚金；情节严重的，处五年以上十年以下有期徒刑，并处五 万元以上五十万元以下罚金；情节特别严重的，处十年以上有期徒刑或者无期徒刑，并处五万元以上五 十万元以下罚金或者没收财产： 伪造、变造金融票证的情形包括四种：(一)伪造、变造汇票、本票、支票的；(二)伪造、变造委托收款 凭证、汇款凭证、银行存单等其他银行结算凭证的；(三)伪造、变造信用证或者附随的单据、文件的； (四)伪造信用卡的。 同时，单位犯前款罪的，对单位判处罚金，并对其直接负责的主管人员和其他直接责任人员，依照前款 的规定处罚。 法官提醒，公众和单位要妥善保管金融票证，关键信息谨防泄。如遇可疑情况，立即核实报警。同时， 要主动维护自身权益，提高防范意识，避免因疏忽造成不必要的损失。 为还债制作假存单，掉包母亲的一张7万元存单。而不知情的母亲在取款时，被银行识破，差点被 抓，"坑"了母亲的小张，也因为伪造行为构成犯罪被判刑。 2022年年初，小张的母亲将7万元钱以定期三年的方式存到了银 ...

Core Viewpoint - The company, Zhejiang Jiuzhou Pharmaceutical Co., Ltd., has announced the use of idle raised funds for cash management, amounting to 200 million RMB, to enhance fund efficiency while ensuring the safety and proper use of the funds [2][4]. Summary by Sections Cash Management Overview - The cash management is aimed at improving fund efficiency and ensuring the safety of the raised funds while not affecting the investment projects [4]. - The total amount allocated for cash management is 200 million RMB [5]. - The funds are sourced from a non-public stock issuance approved by the China Securities Regulatory Commission, raising approximately 2.5 billion RMB [6][7]. Cash Management Details - The cash management products include high-security and liquid investment options such as structured deposits, time deposits, large certificates of deposit, and wealth management products [2][9]. - The cash management period is set for a maximum of 12 months, with individual investment products not exceeding 12 months [2][9]. - The company has previously redeemed cash management products amounting to 21 million RMB, which were returned to the special account for raised funds [3]. Approval Process - The cash management proposal was approved during the 11th meeting of the 8th Board of Directors and the 7th meeting of the 8th Supervisory Board on December 13, 2024 [9]. - The management is authorized to make investment decisions within the approved limits and timeframes [9]. Impact on the Company - The cash management will not affect the normal operation of the company or the implementation of investment projects, ensuring no harm to the interests of the company and its shareholders [14]. - The income generated from cash management will belong to the subsidiary and will be returned to the special account for raised funds upon maturity [8][14].

Core Viewpoint - The company has approved the use of idle raised funds for cash management, amounting to 785 million RMB, to enhance fund efficiency while ensuring the safety and liquidity of investments [1][7][12]. Summary by Sections Cash Management Overview - The cash management is aimed at improving fund efficiency and ensuring the safety of raised funds while not affecting the ongoing investment projects [2][12]. - The cash management products include bank certificates of deposit with a management period of 3, 6, and 12 months [1][7]. Cash Management Amount and Source - The total amount for cash management is 785 million RMB [4][7]. - The funds are sourced from idle raised funds from the company's non-public offerings in 2020 and 2022 [4][6]. Previous Cash Management Activities - The company previously used 21 million RMB of idle funds for cash management, which was redeemed with the principal and earnings returned to the special account for raised funds [2][5]. Approval Process - The cash management proposal was approved in the board meeting held on December 13, 2024, allowing the company to use up to 1.2 billion RMB for cash management under specific conditions [1][9]. Cash Management Product Details - The cash management products are required to be of high safety and liquidity, and the company ensures that these do not alter the intended use of raised funds [7][12]. - The income generated from cash management will belong to the company and will be returned to the special account upon maturity [8][12]. Impact on Company Operations - The use of idle raised funds for cash management will not affect the company's daily operations or the normal implementation of investment projects, aiming to enhance returns for shareholders [12].

Core Viewpoint - The company, Zhejiang Jiuzhou Pharmaceutical Co., Ltd., has announced the establishment of special settlement accounts for cash management of idle raised funds, amounting to 785 million RMB, to enhance the efficiency of fund utilization and ensure the safety of the funds [1][9]. Group 1: Cash Management Overview - The cash management is entrusted to Industrial and Commercial Bank of China and Agricultural Bank of China [1]. - The cash management products include bank certificates of deposit with terms of 3 months, 6 months, and 12 months [1]. - The board of directors approved the use of up to 1.2 billion RMB of idle raised funds for cash management, ensuring it does not affect the construction and use of investment projects [1][9]. Group 2: Account Establishment - The company has opened sub-accounts for cash management at Agricultural Bank of China branches in Taizhou and Changshu [2]. - These accounts will be exclusively used for cash management of idle raised funds and will not be used for other purposes [4]. Group 3: Previous Cash Management Activities - Previously, the company used 21 million RMB of idle funds for cash management, which was redeemed by July 22, 2025, returning the principal and earnings to the special account [4]. Group 4: Purpose and Benefits of Cash Management - The purpose of cash management is to enhance fund efficiency while ensuring the safety of the raised funds and not impacting ongoing investment projects [5][10]. - The income generated from cash management will belong to the company and will be returned to the special account upon maturity [9]. Group 5: Regulatory Compliance - The cash management activities comply with relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [4][10]. - The company has received consent from its sponsor for the cash management activities [10].